<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-05-26</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Og1Jo7RWx">今天正好是搬到SF三周年纪念日。三年前第一天到这里就被Lands End所震撼。早上去Dolye Cafe送别了一个即将去Deep South读PhD的朋友，并给她了一些建议。她在加州...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-og1jo7rwx/">
    
    
    
    
    
      
    
    今天正好是搬到SF三周年纪念日。三年前第一天到这里就被Lands End所震撼。早上去Dolye Cafe送别了一个即将去Deep South读PhD的朋友，并给她了一些建议。她在加州长大，看着她即将搬到南方，好像是我生活在倒带。下午从Lands End一直跑到Palace of Fine Arts，5 miles 8公里。觉得有点低血糖，于是到商店买了瓶Pure Leaf。店员老奶奶看着我然后说“this is sugary, just so you know”，我觉得这句话是SF三周年纪念日的完美写照 - 不是vegetarian、不喝无糖去脂饮料都会被judge一下，这种情景有时候让我觉得很诙谐。今天天气大好，就跟三年前一样，SF这个城市的自然美景让我喜欢的其他城市都逊色。 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og35qxsvh">恭喜@毛豆Papa1104 等2名用户获得【一套《领国者》正版桌游】。微博官方唯一抽奖工具@微博抽奖平台 对本次抽奖进行监督，结果公正有效。公示链接：网页链接 - 转...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og35qxsvh/">
    
    
    
    
    
      
    
    恭喜<!-- raw HTML omitted -->@毛豆Papa1104<!-- raw HTML omitted --> 等2名用户获得【一套《领国者》正版桌游】。微博官方唯一抽奖工具<!-- raw HTML omitted -->@微博抽奖平台<!-- raw HTML omitted --> 对本次抽奖进行监督，结果公正有效。公示链接：<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg">https://h5.sinaimg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og3pR3wmQ">好家伙，维修人员是在堑壕里戴着碟形盔修电脑吗…… [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og3pr3wmq/">
    
    
    
    
    
      
    
    好家伙，维修人员是在堑壕里戴着碟形盔修电脑吗…… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og5Mu7MPd">炒股的可千万不能靠近这里啊…… [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og5mu7mpd/">
    
    
    
    
    
      
    
    炒股的可千万不能靠近这里啊…… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og6f24kS7">昨晚重庆下了一场暴雨，今天气候格外凉爽。下午在解放碑做完活动，忽然来了兴致，决定从朝天门溜达到大坪的龙湖天街，晚上当地朋友在那儿请吃饭。出发前开了导航...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og6f24ks7/">
    
    
    
    
    
      
    
    昨晚重庆下了一场暴雨，今天气候格外凉爽。下午在解放碑做完活动，忽然来了兴致，决定从朝天门溜达到大坪的龙湖天街，晚上当地朋友在那儿请吃饭。<!-- raw HTML omitted --><!-- raw HTML omitted -->出发前开了导航，提示从朝天门到大坪，全程10公里，不过考虑到重庆的地理特点，实际路程绝不止这些。好在重庆是全中国最适合city walk的地方，你永远不知道接下来是一条什么路段，登天入地，钻<!-- raw HTML omitted -->山转岭，时而楼宇林立，时而曲径通幽，变换只在转瞬间。在这里，陌生感变成一种绝佳的佐料，让你时刻保持着惊喜，绝不会无聊。<!-- raw HTML omitted --><!-- raw HTML omitted -->我特意选了一条靠江的路线：先到通远门城墙上吃了一杯茶，然后走到枇杷山，从神仙洞军统办公室旧址前飘过，绕过中山三路，然后可耻地走错了路，进入邹容公园很深才警觉方向错了。一路哭着走出来，本以为前方是 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og6rypbfZ">顺便说一句，快走的时候，手机里随机推了一首王齐铭的《夜郎溪》，既应景又好听，其他歌瞬间都没味道了，反复循环这首直到到终点。下次有机会得去綦江区看看。 -...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og6rypbfz/">
    
    
    
    
    
      
    
    顺便说一句，快走的时候，手机里随机推了一首王齐铭的《夜郎溪》，既应景又好听，其他歌瞬间都没味道了，反复循环这首直到到终点。下次有机会得去綦江区看看。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@马伯庸<!-- raw HTML omitted -->: 昨晚重庆下了一场暴雨，今天气候格外凉爽。下午在解放碑做完活动，忽然来了兴致，决定从朝天门溜达到大坪的龙湖天街，晚上当地朋友在那儿请吃饭。<!-- raw HTML omitted --><!-- raw HTML omitted -->出发前开了导航，提示从朝天门到大坪，全程10公里，不过考虑到重庆的地理特点，实际路程绝不止这些。好在重庆是全中国最适合city walk的地方，你永远不知道接下来是一条什么路段，登天入地，钻<!-- raw HTML omitted -->山转岭，时而楼宇林立，时而曲 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Og7pFm8OE">刚才有个读者很激动地跟我说，感谢你，马老师，让我有机会见到六神磊磊。 我：[喵喵] - 转发 @六神磊磊:&amp;ensp;西西弗问闻书店，热情的读者拿着《食南之徒》找我...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-og7pfm8oe/">
    
    
    
    
    
      
    
    刚才有个读者很激动地跟我说，感谢你，马老师，让我有机会见到六神磊磊。 我：<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@六神磊磊<!-- raw HTML omitted -->: 西西弗问闻书店，热情的读者拿着《食南之徒》找我签。愉快地满足了他。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d87cc410gy1hq3a7i2">https://tvax4.sinaimg.cn/large/d87cc410gy1hq3a7i2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7ALruIX">哦哟，这个ip我在微博还是第一次见//@阿萨有奶茶:我这里，这两样都热销，臭不可闻 - 转发 @包容万物恒河水:&amp;ensp;🔻今日美国，21 世纪，2024 年！🔻这个美国...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7alruix/">
    
    
    
    
    
      
    
    哦哟，这个ip我在微博还是第一次见//<!-- raw HTML omitted -->@阿萨有奶茶<!-- raw HTML omitted -->:我这里，这两样都热销，臭不可闻<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻今日美国，21 世纪，2024 年！<!-- raw HTML omitted -->🔻这个美国人制造的烂梦，还在教导世界其他国家如何生活。<!-- raw HTML omitted -->🔻美国人日常使用大 麻的人数已经超过使用酒精的了（数据源：WSJ）。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaim">https://tvax4.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7CLp3VB">🔻“我妈已经三天没有打我啦”🔻不想睡午觉的小孩怎么都一个样？🔻via 莫动园长</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7clp3vb/">
    
    
    
    
    
      
    
    🔻“我妈已经三天没有打我啦”<!-- raw HTML omitted -->🔻不想睡午觉的小孩怎么都一个样？<!-- raw HTML omitted -->🔻via 莫动园长 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/Qqmh4khblx08fairoBHi01041200amYP0E010.mp4?label=mp4_hd&amp;amp;template=540x960.24">https://f.video.weibocdn.com/o0/Qqmh4khblx08fairoBHi01041200amYP0E010.mp4?label=mp4_hd&amp;amp;template=540x960.24</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7ElvcNB">🔻“哈尔科夫地区的战斗中，8名俄罗斯人才能换1名乌克兰人“——泽连斯基说，他经常收到这样的统计数据。🔻不过，之前他也声称得到了有关哈尔科夫防御工事固...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7elvcnb/">
    
    
    
    
    
      
    
    🔻“哈尔科夫地区的战斗中，8名俄罗斯人才能换1名乌克兰人“——泽连斯基说，他经常收到这样的统计数据。<!-- raw HTML omitted -->🔻不过，之前他也声称得到了有关哈尔科夫防御工事固若金汤的统计数据，但这些数据是错误的。<!-- raw HTML omitted -->🔻via vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.sinaimg.cn/orj480/639b1bfbly1hq3cdy29fk">https://tvax2.sinaimg.cn/orj480/639b1bfbly1hq3cdy29fk</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7FCreY7">🔻[哆啦A梦吃惊] [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7fcrey7/">
    
    
    
    
    
      
    
    🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7gUiCd5">🔻红旗 N701 正在翻越法国图尔马莱山口。🔻2024年5月，总台央视记者张晓鹏、郭鸿摄。 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7guicd5/">
    
    
    
    
    
      
    
    🔻红旗 N701 正在翻越法国图尔马莱山口。<!-- raw HTML omitted -->🔻2024年5月，总台央视记者张晓鹏、郭鸿摄。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7IqtUqf">🔻2024/05/26/11:20🔻美国空军，光学/信号情报收集飞机 RC-135S 61-2662。🔻从嘉手纳空军基地起飞，在黄海附近海域盘旋。🔻via F24 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7iqtuqf/">
    
    
    
    
    
      
    
    🔻2024/05/26/11:20<!-- raw HTML omitted -->🔻美国空军，光学/信号情报收集飞机 RC-135S 61-2662。<!-- raw HTML omitted -->🔻从嘉手纳空军基地起飞，在黄海附近海域盘旋。<!-- raw HTML omitted -->🔻via F24 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7K9s0pX">🔻？ 🔻后四张为电影《沙丘》 [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7k9s0px/">
    
    
    
    
    
      
    
    🔻？ <!-- raw HTML omitted -->🔻后四张为电影《沙丘》 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hq3cth9pji">https://tvax2.sinaimg.cn/large/639b1bfbly1hq3cth9pji</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7udjrrk">🔻三天不打，上房揭瓦。🔻via 莫动园长 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7udjrrk/">
    
    
    
    
    
      
    
    🔻三天不打，上房揭瓦。<!-- raw HTML omitted -->🔻via 莫动园长 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/BInKJct5lx08fah1gygo01041200">https://f.video.weibocdn.com/o0/BInKJct5lx08fah1gygo01041200</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7Xfa2km">掐指算了算，我有生之年肯定看得到。//@Dekafire:[哆啦A梦吃惊]是我梦中出现过的感觉！！！！没想到真的能看见，不过我梦中这个场景是在火星[哆啦A梦吃惊] - 转...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7xfa2km/">
    
    
    
    
    
      
    
    掐指算了算，我有生之年肯定看得到。//<!-- raw HTML omitted -->@Dekafire<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->是我梦中出现过的感觉！！！！没想到真的能看见，不过我梦中这个场景是在火星<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a href=&ldquo;<a href="https://weibo.com/1671109627%22">https://weibo.com/1671109627&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Og7yFa1NT">🔻还是今天悉尼的这次赛斯纳 T210M Turbo Centurion（VH-MYW）飞机紧 急 迫 降。🔻在失去动力后，飞行员竭尽全力将飞机保持在失速以上，没有任何可能导致失...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-og7yfa1nt/">
    
    
    
    
    
      
    
    🔻还是今天悉尼的这次赛斯纳 T210M Turbo Centurion（VH-MYW）飞机紧 急 迫 降。<!-- raw HTML omitted -->🔻在失去动力后，飞行员竭尽全力将飞机保持在失速以上，没有任何可能导致失速的不必要操作。<!-- raw HTML omitted -->🔻他甚至连起落架都没有放，在无襟翼的情况下升档拉伸滑行。<!-- raw HTML omitted -->🔻飞机的影子在下面的建筑物上越来越大……在最后一秒他决定放弃主跑道，在滑行道上机腹迫 降，没有一个东西是多余的。<!-- raw HTML omitted -->🔻多一个操作就撞在地面建筑上了，至少最后一个仓库肯定飞不过去。<!-- raw HTML omitted -->🔻精彩。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Og8dkif6D">谁会喜欢阴暗批啊[单身狗]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-og8dkif6d/">
    
    
    
    
    
      
    
    谁会喜欢阴暗批啊<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og25qj7D4">冯老夫子自道[哈哈] - 转发 @成都冯川:&amp;ensp;#旧博重发# 图书馆可能是躲老婆躲家务事的好地方。每次去洛萨托斯图书馆，都会看见一40岁左右华裔男子，坐在同一个...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og25qj7d4/">
    
    
    
    
    
      
    
    冯老夫子自道<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@成都冯川<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#旧博重发#&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og2e43XSx">看看香港就知道//@成都冯川://@茨冈女神:[鲜花] - 转发 @糖糖的VV博:&amp;ensp;笑谈英吉利笑谈英吉利 笑谈英吉利</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og2e43xsx/">
    
    
    
    
    
      
    
    看看香港就知道//<!-- raw HTML omitted -->@成都冯川<!-- raw HTML omitted -->://<!-- raw HTML omitted -->@茨冈女神<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@糖糖的VV博<!-- raw HTML omitted -->: 笑谈英吉利<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og2ZM39dR">AI是现在一个热门话题，据说很多行业职业将会被AI替代，如文秘、教师、医生、律师、设计类工程师等等。我想体验一下AI写作，于是下载“文心一言”，先让它写我上...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og2zm39dr/">
    
    
    
    
    
      
    
    AI是现在一个热门话题，据说很多行业职业将会被AI替代，如文秘、教师、医生、律师、设计类工程师等等。我想体验一下AI写作，于是下载“文心一言”，先让它写我上初中时写过的作文，《记一次学农劳动》《难忘的一天》《唱国际歌所想到的》等，篇篇文从字顺，但缺乏个性和灵气，没有我初中作文水平高。再让它写一篇学术论文《论朱熹的“淫诗”之说》，生成的文章，只能算介绍性文字，跟我发表在《西南师大学报》上的《朱熹“淫诗”之说平议》，不在同一档次。最后让它写两位官员发言稿，同一个题目：鼓励年轻人婚育。生成的两篇发言稿，并不雷同，也比较符合乡镇官员的身份。看来，现在的AI可能比较适合写官样文章。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/d1840ee6gy1hq2rp9rcd7">https://tvax3.sinaimg.cn/large/d1840ee6gy1hq2rp9rcd7</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og4MR8qG4">AI绘画，笑死人 [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og4mr8qg4/">
    
    
    
    
    
      
    
    AI绘画，笑死人 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hq2zpnd3p4j20xw230ame.jpg">https://tvax4.sinaimg.cn/large/d1840ee6gy1hq2zpnd3p4j20xw230ame.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og5LlcFj5">AI写的劝婚信和劝生二胎三胎信，比喵爷爷写得好[赞][赞] [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og5llcfj5/">
    
    
    
    
    
      
    
    AI写的劝婚信和劝生二胎三胎信，比喵爷爷写得好<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hq340q7g1zj20xw230wu">https://tvax4.sinaimg.cn/large/d1840ee6gy1hq340q7g1zj20xw230wu</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Og6arp7kr">AI写作的2024年四川大学毕业典礼暨授位仪式教师代表致辞及古体诗词《送川大学子毕业》。超过了很多文秘的水平吧？其实，现实生活中的很多致辞和文字，都只是一种...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-og6arp7kr/">
    
    
    
    
    
      
    
    AI写作的2024年四川大学毕业典礼暨授位仪式教师代表致辞及古体诗词《送川大学子毕业》。超过了很多文秘的水平吧？其实，现实生活中的很多致辞和文字，都只是一种仪式，不太需要真情实感和文章个性，能达到AI写作的这种水平，足矣。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaim">https://tvax3.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Og1DFnsDD">拍了个肺CT，结论是需要减肥👿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-og1dfnsdd/">
    
    
    
    
    
      
    
    拍了个肺CT，结论是需要减肥👿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Og3cJd1PZ">这B甲流比TM新冠还要命😅</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-og3cjd1pz/">
    
    
    
    
    
      
    
    这B甲流比TM新冠还要命😅  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Og3nxE0Vf">丁浩衣服搞特殊是吧👿 - 转发 @龙元明城杭州队:&amp;ensp;在即将到来的2024年围甲比赛，龙元明城杭州队将再次崭露锋芒，踏上挑战自我的新征途。他们，是智慧的勇士...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-og3nxe0vf/">
    
    
    
    
    
      
    
    丁浩衣服搞特殊是吧👿<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@龙元明城杭州队<!-- raw HTML omitted -->: 在即将到来的2024年围甲比赛，龙元明城杭州队将再次崭露锋芒，踏上挑战自我的新征途。他们，是智慧的勇士，是棋盘的征服者。就让我们见证他们在赛场上披荆斩棘，勇往直前，用智慧与勇气点亮这场围棋盛宴的每一个角落！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;s &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Og5ZhxAy2">[二哈] [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-og5zhxay2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og4XG7K54">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 线下见面会in幕张展览馆感谢大家☺️稍后18:00～（JST）文化放送『乃木坂46的「の」』请一定要听～跟...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og4xg7k54/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23s">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og6itcO5v">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木のの&amp;乃木坂46 X [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og6itco5v/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木のの&amp;乃木坂46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hq31u78qpuj31400u07ck.jpg">https://tvax4.sinaimg.cn/large/006z6nxLgy1hq31u78qpuj31400u07ck.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og6iw90Qm">//@顶筆TEN使:久保史绪里[爱你][爱你] - 转发 @向井葉月_向日葵official:&amp;ensp;向井叶月#向井叶月# 5/26 17:46「向井叶月message」 线下见面会真的很开心啊～�...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og6iw90qm/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[爱你]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_aini-09d5f3f870.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_aini-09d5f3f870.png&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og6vyxtOs">转发微博 - 转发 @剑网3官方微博:&amp;ensp;#剑网3无界定档# 6月13日手机上玩剑网3！就等你啦！✦ 这个夏天起摇人上号，随叫随上！评论区随机抽10位幸运侠士送上【61...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og6vyxtos/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@剑网3官方微博<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#剑网3无界定档#<!-- raw HTML omitted --><!-- raw HTML omitted --> 6月13日手机上玩剑网3！就等你啦！<!-- raw HTML omitted --><!-- raw HTML omitted -->✦ 这个夏天起摇人上号，随叫随上！评论区随机抽10位幸运侠士送上【613元】现金红包！再抽100位幸运侠士送上【66元】现金红包！两个时间千万不要忘了哟~<!-- raw HTML omitted -->✦ 15岁了！轮到孩子送侠士们上广告大屏啦！！！转关抽1位幸运侠士上商场大屏广告！后续还将有更大大大大的巨型打卡点~&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og6xRrXY6">送我 - 转发 @剑网3官方微博:&amp;ensp;#剑网3无界定档# 6月13日！手机上能玩剑网3啦！福利四连先送上~欢迎大家都来玩剑网3！转关抽10位幸运侠士【100000通宝】@微博...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og6xrrxy6/">
    
    
    
    
    
      
    
    送我<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@剑网3官方微博<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#剑网3无界定档#<!-- raw HTML omitted --><!-- raw HTML omitted --> 6月13日！手机上能玩剑网3啦！福利四连先送上~欢迎大家都来玩剑网3！转关抽10位幸运侠士【100000通宝】<!-- raw HTML omitted -->@微博抽奖平台<!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og7Ppjjk5">//@顶筆TEN使:久保史绪里[耶][耶] - 转发 @菅原咲月字幕组:&amp;ensp;2024.05.26 message ⑥18点〜是「乃木のの」！和史绪里前辈聊了好多🐳※内容为自费购买 请勿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og7ppjjk5/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[耶]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og7vmfEMG">好喜欢姐姐，真的好喜欢姐姐</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og7vmfemg/">
    
    
    
    
    
      
    
    好喜欢姐姐，真的好喜欢姐姐  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og8A62gtM">想吃饺子</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og8a62gtm/">
    
    
    
    
    
      
    
    想吃饺子  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og8BTf7IX">改了新id之后觉得自己清爽多了（</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og8btf7ix/">
    
    
    
    
    
      
    
    改了新id之后觉得自己清爽多了（  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Og8y6sUHA">好好好 - 转发 @剑网3官方微博:&amp;ensp;#剑网3无界定档# 这个大喜日子再送点啥嘞？把老板车也拿来送了吧！现车送货上门！全网独一份10年使用权，小米SU7 Max 创始...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-og8y6suha/">
    
    
    
    
    
      
    
    好好好<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@剑网3官方微博<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#剑网3无界定档#<!-- raw HTML omitted --><!-- raw HTML omitted --> 这个大喜日子再送点啥嘞？把老板车也拿来送了吧！现车送货上门！全网独一份10年使用权，小米SU7 Max 创始版带回家~<!-- raw HTML omitted -->来一起打造剑网3侠士专属痛车吧！痛什么，由你来定！十九门派？黄鸡大笑？水墨圈圈？欢迎侠士转发评论留下脑洞和建议，如被采纳即可获得666元才华奖金！&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Og5C0jmEJ">比夏巡棒球制服好看多了 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.05.25 20:03「非常」不 这不是制服嘛 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-og5c0jmej/">
    
    
    
    
    
      
    
    比夏巡棒球制服好看多了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Og5CvcaUS">成熟美 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 线下见面会in幕张展览馆感谢大家☺️稍后18:00～（JST）文化放送『乃木坂46的「の」』请一定要听～跟咲...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-og5cvcaus/">
    
    
    
    
    
      
    
    成熟美<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23sh">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23sh</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Og7d8gRk4">成熟保 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.05.26 22:26「呜呼呼」线下见面会感谢大家！！阿叶（Haju）～～～～ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-og7d8grk4/">
    
    
    
    
    
      
    
    成熟保<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og4Tu5M3e">久保史绪里#shiorigram# 线下见面会in幕张展览馆感谢大家☺️稍后18:00～（JST）文化放送『乃木坂46的「の」』请一定要听～跟咲月聊了很多开心的话题哦☺️ [图...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og4tu5m3e/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og4YUmYwS">久保史绪里via.乃木のの&amp;乃木坂46 X [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og4yumyws/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木のの&amp;乃木坂46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy">https://tvax4.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og5g28yOJ">增加一张 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.乃木のの&amp;乃木坂46 X [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og5g28yoj/">
    
    
    
    
    
      
    
    增加一张<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.乃木のの&amp;乃木坂46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hq31u78qpuj31400u07ck.jpg">https://tvax4.sinaimg.cn/large/006z6nxLgy1hq31u78qpuj31400u07ck.jpg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og5g8AbSK">久保史绪里[爱你][爱你] - 转发 @向井葉月_向日葵official:&amp;ensp;向井叶月#向井叶月# 5/26 17:46「向井叶月message」 线下见面会真的很开心啊～😸✨ 谢谢特意...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og5g8absk/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og6T21Bn8">久保史绪里#久保史绪里手机博# 2024.05.26 22:26「呜呼呼」线下见面会感谢大家！！阿叶（Haju）～～～～ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og6t21bn8/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og6T9i3qO">久保史绪里#久保史绪里手机博# 2024.05.26 22:28「哦吼吼」感觉吃饱了因为好好吃东西了，所以在觉得困前要做必须要做的事喽！！！！哦哟哟</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og6t9i3qo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Og7LAE15s">久保史绪里[耶][耶] - 转发 @菅原咲月字幕组:&amp;ensp;2024.05.26 message ⑥18点〜是「乃木のの」！和史绪里前辈聊了好多🐳※内容为自费购买 请勿转载至外网#sat...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-og7lae15s/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6117592326/Og8BirHxt"></a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6117592326-og8birhxt/">
    
    
    
    
    
      
    
    NA &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Og6cfwiNc">柯洁#2024乐居乐杯中国围棋甲级联赛##赛事预告# 围甲第一轮，柯洁九段与快棋台迎战伊凌涛八段 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-og6cfwinc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Og6sVrWoA">我们深圳龙华是不可战胜的[赢牛奶][赢牛奶][赢牛奶] - 转发 @棋士柯洁:&amp;ensp;今天收到了超级特别的礼物[送花花]非常感谢！实在是太有心了[赢牛奶]真的特别开心�...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-og6svrwoa/">
    
    
    
    
    
      
    
    我们深圳龙华是不可战胜的<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[赢牛奶]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/9c/2021_yingniunai_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/9c/2021_yingniunai_org.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699921420">量子位发表了文章: Hinton揭秘Ilya成长历程：Scaling Law是他学生时代就有的直觉</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699921420/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699929135">王诗翔发表了文章: 生信爱好者周刊（第 124 期）：《Cell》癌症研究五十年：十大要点总结</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-26</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699929135/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38790204/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38790204-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Induced pluripotent stem cells (iPSCs) are a powerful tool for biomedical research, but their production presents challenges and safety concerns. Yamanaka and Takahashi revolutionised the field by demonstrating that somatic cells could be reprogrammed into pluripotent cells by overexpressing four key factors for a sufficient time. iPSCs are typically generated using viruses or virus-based methods, which have drawbacks such as vector persistence, risk of insertional mutagenesis, and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38790531/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Quality of Life of Children with Short Bowel Syndrome from Patients&#39; and Parents&#39; Points of View</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38790531-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite limited research, existing studies using generic quality of life (QOL) tools indicate decreased physical health and compromised emotional functioning in children with IF. This study investigates QOL in children with short bowel syndrome (SBS) and its determinants. The study included 57 pediatric patients with SBS treated at Mannheim&rsquo;s University Hospital between 1998 and 2014. To evaluate QOL, the KINDL questionnaire was used. Three age-specific questionnaire variants were employed, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38790994/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38790994-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Kidney involvement with resulting kidney failure leads to increased mortality in patients with multiple myeloma (MM). Cast nephropathy (CN), in particular, if left untreated, quickly leads to kidney failure requiring dialysis and has a very poor prognosis for the affected patient. The gold standard for diagnosing kidney involvement is a kidney biopsy. However, due to bleeding risk, this cannot be done in every patient. We recently reported that a quotient of urine light chain (LCurine) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791079/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791079-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent advances in the treatment of gastric cancer (GC) with chemotherapy, immunotherapy, anti-angiogenic therapy and targeted therapies have yielded some improvement in survival outcomes; however, metastatic GC remains a lethal malignancy and amongst the leading causes of cancer-related mortality worldwide. Importantly, the ongoing molecular characterisation of GCs continues to uncover potentially actionable molecular targets. Among these, aberrant FGFR2-driven signalling, predominantly &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791144/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">The Role of Methylation Analysis in Distinguishing Cellular Myxoma from Low-Grade Myxofibrosarcoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791144-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cellular myxoma is a benign soft tissue tumor frequently associated with GNAS mutation that may morphologically resemble low-grade myxofibrosarcoma. This study aimed to identify the undescribed methylation profile of cellular myxoma and compare it to myxofibrosarcoma. We performed molecular analysis on twenty cellular myxomas and nine myxofibrosarcomas and analyzed the results using the methylation-based DKFZ sarcoma classifier. A total of 90% of the cellular myxomas had GNAS mutations &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791414/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791414-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Chemokines orchestrate many aspects of tumorigenic processes such as angiogenesis, apoptosis and metastatic spread, and related receptors are expressed on tumor cells as well as on inflammatory cells (e.g., tumor-infiltrating T cells, TILs) in the tumor microenvironment. Expressional changes of chemokines and their receptors in solid cancers are common and well known, especially in affecting colorectal cancer patient outcomes. Therefore, the aim of this current systematic review &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791501/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis-A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791501-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Sepsis is a life-threatening syndrome triggered by infection and accompanied by high mortality, with antimicrobial resistances (AMRs) further escalating clinical challenges. The rapid and reliable detection of causative pathogens and AMRs are key factors for fast and appropriate treatment, in order to improve outcomes in septic patients. However, current sepsis diagnostics based on blood culture is limited by low sensitivity and specificity while current molecular approaches fail to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791920/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791920-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The standard treatment for locally advanced cervical cancer typically includes concomitant chemoradiation, a regimen known to induce severe hematologic toxicity (HT). Particularly, pelvic bone marrow dose exposure has been identified as a contributing factor to this hematologic toxicity. Chemotherapy further increases bone marrow suppression, often necessitating treatment interruptions or dose reductions. A systematic search for original articles published between 1 January 2006 and 7 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791936/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">What Is a Sarcoma &#39;Specialist Center&#39;? Multidisciplinary Research Finds an Answer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791936-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The management of sarcomas in specialist centers delivers significant benefits. In much of the world, specialists are not available, and the development of expertise is identified as a major need. However, the terms &lsquo;specialist&rsquo; or &lsquo;expert&rsquo; center are rarely defined. Our objective is to offer a definition for patient advocates and a tool for healthcare providers to underpin improving the care of people with sarcoma. SPAGN developed a discussion paper for a workshop at the SPAGN 2023 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791956/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791956-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The overexpression of somatostatin receptor type 2 (SSTR2) is a property of various tumor types. Hybrid imaging utilizing [^(68)Ga]1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra-acetic acid (DOTA) may improve the differentiation between tumor and healthy tissue. We conducted an experimental study on 47 anonymized patient cases including 30 meningiomas, 12 PitNET and 5 SBPGL. Four independent observers were instructed to contour the macroscopic tumor volume on planning MRI and then reassess &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38791979/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38791979-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are key regulators of blood vessel formation, including in tumors, where their deregulated function can promote the production of aberrant, leaky blood vessels, supporting tumor development. Here we investigated the VEGFR1 ligand VEGF-B, which we demonstrate to be expressed in tumor cells and in tumor stroma and vasculature across a range of tumor types. We examined the anti-VEGF-B-specific monoclonal antibody 2H10 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38792272/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Outcome of Pulmonary Embolism with and without Ischemic Stroke</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38792272-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Ischemic stroke is the second, and pulmonary embolism (PE) is the third most common cardiovascular cause of death after myocardial infarction. Data regarding risk factors for ischemic stroke in patients with acute PE are limited. Methods: Patients were selected by screening the German nationwide in-patient sample for PE (ICD-code I26) and were stratified by ischemic stroke (ICD code I63) and compared. Results: The nationwide in-patient sample comprised 346,586 hospitalized &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38792272/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Outcome of Pulmonary Embolism with and without Ischemic Stroke</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38792272-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Ischemic stroke is the second, and pulmonary embolism (PE) is the third most common cardiovascular cause of death after myocardial infarction. Data regarding risk factors for ischemic stroke in patients with acute PE are limited. Methods: Patients were selected by screening the German nationwide in-patient sample for PE (ICD-code I26) and were stratified by ischemic stroke (ICD code I63) and compared. Results: The nationwide in-patient sample comprised 346,586 hospitalized &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38793691/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38793691-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In patients with COVID-19, broad panels of immune checkpoint molecules (ICPMs) and the purinergic signaling have not been studied in parallel. We aimed to perform in-depth immunophenotyping of major cell subsets present in human peripheral blood of COVID-19 patients and controls using PD1, TIM3, LAG3, TIGIT, and CD200R, as well as CD39, as markers for the purinergic signaling pathway. We studied 76 COVID-19 patients and 12 healthy controls using peripheral blood mononuclear cells on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38793691/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38793691-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In patients with COVID-19, broad panels of immune checkpoint molecules (ICPMs) and the purinergic signaling have not been studied in parallel. We aimed to perform in-depth immunophenotyping of major cell subsets present in human peripheral blood of COVID-19 patients and controls using PD1, TIM3, LAG3, TIGIT, and CD200R, as well as CD39, as markers for the purinergic signaling pathway. We studied 76 COVID-19 patients and 12 healthy controls using peripheral blood mononuclear cells on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38793784/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38793784-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Merkel cell carcinoma is a rare, aggressive skin cancer that mainly occurs in elderly and immunocompromised patients. Due to the success of immune checkpoint inhibition in MCC, the importance of immunotherapy and vaccines in MCC has increased in recent years. In this article, we aim to present the current progress and perspectives in the development of vaccines for this disease. Here, we summarize and discuss the current literature and ongoing clinical trials investigating vaccines against &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38793784/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38793784-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Merkel cell carcinoma is a rare, aggressive skin cancer that mainly occurs in elderly and immunocompromised patients. Due to the success of immune checkpoint inhibition in MCC, the importance of immunotherapy and vaccines in MCC has increased in recent years. In this article, we aim to present the current progress and perspectives in the development of vaccines for this disease. Here, we summarize and discuss the current literature and ongoing clinical trials investigating vaccines against &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794114/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">In Silico Design of Potential Small-Molecule Antibiotic Adjuvants against &lt;em&gt;Salmonella typhimurium&lt;/em&gt; Ortho Acetyl Sulphydrylase Synthase to Address Antimicrobial Resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794114-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The inhibition of O-acetyl sulphydrylase synthase isoforms has been reported to represent a promising approach for the development of antibiotic adjuvants. This occurs via the organism developing an unpaired oxidative stress response, causing a reduction in antibiotic resistance in vegetative and swarm cell populations. This consequently increases the effectiveness of conventional antibiotics at lower doses. This study aimed to predict potential inhibitors of Salmonella typhimurium ortho &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794114/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">In Silico Design of Potential Small-Molecule Antibiotic Adjuvants against &lt;em&gt;Salmonella typhimurium&lt;/em&gt; Ortho Acetyl Sulphydrylase Synthase to Address Antimicrobial Resistance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794114-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The inhibition of O-acetyl sulphydrylase synthase isoforms has been reported to represent a promising approach for the development of antibiotic adjuvants. This occurs via the organism developing an unpaired oxidative stress response, causing a reduction in antibiotic resistance in vegetative and swarm cell populations. This consequently increases the effectiveness of conventional antibiotics at lower doses. This study aimed to predict potential inhibitors of Salmonella typhimurium ortho &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pharmacy compounding, the art and science of preparing customized medications to meet individual patient needs, is on the verge of transformation. Traditional methods of compounding often involve manual and time-consuming processes, presenting challenges in terms of consistency, dosage accuracy, quality control, contamination, and scalability. However, the emergence of cutting-edge technologies has paved a way for a new era for pharmacy compounding, promising to redefine the way medications &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Pharmacy compounding, the art and science of preparing customized medications to meet individual patient needs, is on the verge of transformation. Traditional methods of compounding often involve manual and time-consuming processes, presenting challenges in terms of consistency, dosage accuracy, quality control, contamination, and scalability. However, the emergence of cutting-edge technologies has paved a way for a new era for pharmacy compounding, promising to redefine the way medications &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794726/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Effect of Lifestyle Counselling via a Mobile Application on Disease Activity Control in Inflammatory Arthritis: A Single-Blinded, Randomized Controlled Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794726-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Individualized lifestyle and dietary counselling via app may help to improve disease control in inflammatory arthritis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794726/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Effect of Lifestyle Counselling via a Mobile Application on Disease Activity Control in Inflammatory Arthritis: A Single-Blinded, Randomized Controlled Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794726-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Individualized lifestyle and dietary counselling via app may help to improve disease control in inflammatory arthritis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794800/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240525190013&amp;v=2.18.0.post9&#43;e462414">Scrutinising delay in leprosy diagnosis in Colombia: perceptions and experiences by leprosy health professionals</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794800-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240525190013-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Leprosy is an infectious neglected tropical disease, which can cause irreversible disabilities if not diagnosed in time. Colombia continues to show high rates of leprosy-related disability, mainly due to a delay in diagnosis. Limited knowledge is available that explains this delay, therefore our study aimed to explore the perceptions and experiences of leprosy health professionals with the delay in leprosy diagnosis in the Cesar and Valle del Cauca departments, Colombia. Nine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38794800/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Scrutinising delay in leprosy diagnosis in Colombia: perceptions and experiences by leprosy health professionals</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38794800-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Leprosy is an infectious neglected tropical disease, which can cause irreversible disabilities if not diagnosed in time. Colombia continues to show high rates of leprosy-related disability, mainly due to a delay in diagnosis. Limited knowledge is available that explains this delay, therefore our study aimed to explore the perceptions and experiences of leprosy health professionals with the delay in leprosy diagnosis in the Cesar and Valle del Cauca departments, Colombia. Nine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795065/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">WeSA: a web server for improving analysis of affinity proteomics data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795065-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Protein-protein interaction experiments still yield many false positive interactions. The socioaffinity metric can distinguish true protein-protein interactions from noise based on available data. Here, we present WeSA (Weighted SocioAffinity), which considers large datasets of interaction proteomics data (IntAct, BioGRID, the BioPlex) to score human protein interactions and, in a statistically robust way, flag those (even from a single experiment) that are likely to be false positives. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795111/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Myocardial Mitochondrial Function Is Impaired in Cardiac Light-Chain Amyloidosis Compared to Transthyretin Amyloidosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795111-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795348/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795348-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lysine deacetylase inhibitors (KDACis) are approved drugs for cutaneous T cell lymphoma (CTCL), peripheral T cell lymphoma (PTCL), and multiple myeloma, but many aspects of their cellular mechanism of action (MoA) and substantial toxicity are not well understood. To shed more light on how KDACis elicit cellular responses, we systematically measured dose-dependent changes in acetylation, phosphorylation, and protein expression in response to 21 clinical and pre-clinical KDACis. The &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795348/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240526182221&amp;v=2.18.0.post9&#43;e462414">Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795348-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240526182221-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Lysine deacetylase inhibitors (KDACis) are approved drugs for cutaneous T cell lymphoma (CTCL), peripheral T cell lymphoma (PTCL), and multiple myeloma, but many aspects of their cellular mechanism of action (MoA) and substantial toxicity are not well understood. To shed more light on how KDACis elicit cellular responses, we systematically measured dose-dependent changes in acetylation, phosphorylation, and protein expression in response to 21 clinical and pre-clinical KDACis. The &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795701/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Empowering virus-free CAR immune cell therapies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795701-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795735/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Cold versus Hot Snare Endoscopic Resection of Large Non-Pedunculated Colorectal Polyps (Randomized-controlled German CHRONICLE-trial)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795735-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Cold resection of large non-pedunculated colorectal polyps appears considerably safer than hot EMR, however at the cost of a higher residual adenoma rate. Further studies have to confirm to which extent polyp size and histology can determine an individualized approach (Trial number: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795867/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Diabetic retinopathy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795867-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795869/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Response to Letter to the Editor: &#34;Discrepancies in reported prevalence rates of keratoconus in Russia&#34;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795869-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38795877/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Emerging Role of Circulating Cell-Free RNA as a Non-Invasive Biomarker for Hepatocellular Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38795877-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is a severe neoplastic disease associated with high morbidity and mortality rates. HCC is often detected at advanced stages leading to ineffective curative treatments. Recently, liquid biopsy has emerged as a non-invasive method to identify highly specific HCC biomarkers in bodily fluids such as blood, serum, urine, and saliva. Circulating cell-free nucleic acids (cfNAs), particularly cell-free DNA (cfDNA) and cell-free RNA (cfRNA), have become promising &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796065/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Splice variants of CK1α and CK1α-like: Comparative analysis of subcellular localization, kinase activity and function in the Wnt signaling pathway</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796065-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Members of the casein kinase 1 (CK1) family are important regulators of multiple signaling pathways. CK1α is a well-known negative regulator of the Wnt/β-catenin pathway, which promotes the degradation of β-catenin via its phosphorylation of Ser45. In contrast, the closest paralog of CK1α, CK1α-like, is a poorly characterized kinase of unknown function. In this study we show that the deletion of CK1α, but not CK1α-like, resulted in a strong activation of the Wnt/β-catenin pathway. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796125/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">A translational neuroscience perspective on loneliness: Narrative review focusing on social interaction, illness and oxytocin</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796125-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This review addresses key findings on loneliness from the social, neurobiological and clinical fields. From a translational perspective, results from studies in humans and animals are included, with a focus on social interaction, mental and physical illness and the role of oxytocin in loneliness. In terms of social interactions, lonely individuals tend to exhibit a range of abnormal behaviors based on dysfunctional social cognitions that make it difficult for them to form &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796187/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">The effects of upward revision of haemoglobin thresholds for anaemia in blood donations - Authors&#39; reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796187-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796285/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796285-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796378/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1byXLWG-5Hn0_qdLgZYpDfLA2UWGhGNgZGereuo1rJN2aoAQXP&amp;fc=20220814223158&amp;ff=20240526181713&amp;v=2.18.0.post9&#43;e462414">Radiomics model and deep learning model based on T1WI image for acute lymphoblastic leukemia identification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796378-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1byxlwg-5hn0-qdlgzypdfla2uwghgngzgereuo1rjn2aoaqxp-fc-20220814223158-ff-20240526181713-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The deep learning and radiomics models showed high AUC values in the training and test cohorts. They also exhibited good diagnostic efficacy for predicting &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240526182223&amp;v=2.18.0.post9&#43;e462414">SpatialPrompt: spatially aware scalable and accurate tool for spot deconvolution and domain identification in spatial transcriptomics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240526182223-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Efficiently mapping of cell types in situ remains a major challenge in spatial transcriptomics. Most spot deconvolution tools ignore spatial coordinate information and perform extremely slow on large datasets. Here, we introduce SpatialPrompt, a spatially aware and scalable tool for spot deconvolution and domain identification. SpatialPrompt integrates gene expression, spatial location, and single-cell RNA sequencing (scRNA-seq) dataset as reference to accurately infer cell-type proportions &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38796545/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240526182247&amp;v=2.18.0.post9&#43;e462414">The SPECTRAL Perfusion Arm Clamping dAtaset (SPECTRALPACA) for video-rate functional imaging of the skin</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38796545-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240526182247-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spectral imaging has the potential to become a key technique in interventional medicine as it unveils much richer optical information compared to conventional RBG (red, green, and blue)-based imaging. Thus allowing for high-resolution functional tissue analysis in real time. Its higher information density particularly shows promise for the development of powerful perfusion monitoring methods for clinical use. However, even though in vivo validation of such methods is crucial for their &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OfSbB9AVh">Science Trans Med发表了Gilead和Yale的Martinez合作研究，报道了Gilead开发的RdRp抑制剂、冠状病毒小分子抗病毒药Remdesivir口服形式GS-5245（Obeldesivir）的...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ofsbb9avh/">
    
    
    
    
    
      
    
    Science Trans Med发表了Gilead和Yale的Martinez合作研究，报道了Gilead开发的RdRp抑制剂、冠状病毒小分子抗病毒药Remdesivir口服形式GS-5245（Obeldesivir）的临床前有效性结果。ODV除了可以高效抑制新型冠状病毒SARS-CoV-2原始型WA1，还可以抑制多种冠状病毒，包括SARS-CoV-1、RsSHC014、和MERS-CoV。ODV在BALB/c小鼠体内高效抑制SARS-CoV-2 MA10；而在K18-ACE2转基因小鼠中，ODV可以抑制SARS-CoV-2 Omicron和RsSHC014感染。ODV还在BALB/c小鼠体内表现出高效治疗SARS-CoV MA15感染的体内活性，并在DPP4小鼠中有效逆转MERS-CoV感染。ODV + Paxlovid有效成份nirmatrelvir可以全面消除SARS-CoV-2感染。这一系列数据显示，ODV是一种潜在的高效口服泛冠状病毒抗病毒药物。ODV的临床试验（NCT0 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OfVJj1PPF">有桌游圈的朋友提醒，昨天玩的是盗版[允悲]。为了表示歉意和弥补，我自己买了三套正版，一套自己收藏，两套抽奖。明天中午12点开奖，只要转发就可以参加。请大家...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ofvjj1ppf/">
    
    
    
    
    
      
    
    有桌游圈的朋友提醒，昨天玩的是盗版<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->。为了表示歉意和弥补，我自己买了三套正版，一套自己收藏，两套抽奖。明天中午12点开奖，只要转发就可以参加。请大家支持正版店铺（附图）。 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/OfWg1ktlm">[鲜花][鲜花][鲜花] - 转发 @七分溏心:&amp;ensp;宋雨琦 240525 延世校庆怼脸 正确的©️pasassak 七分溏心的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ofwg1ktlm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OfU2tlZjP">五一节逛Sam&#39;s Club，喵奶奶坚持要买一盒六片装的澳洲牛排，我说煎牛排没有辣椒炒牛肉丝好吃，她说我觉得煎牛排好吃。买回来吃了两片，全熟或半生不熟，都尝试过...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ofu2tlzjp/">
    
    
    
    
    
      
    
    五一节逛Sam&rsquo;s Club，喵奶奶坚持要买一盒六片装的澳洲牛排，我说煎牛排没有辣椒炒牛肉丝好吃，她说我觉得煎牛排好吃。买回来吃了两片，全熟或半生不熟，都尝试过，不怎么样。今天创新一哈，一牛两吃：黄油煎牛排vs 辣椒牛肉丝。吃后感，还是中国的辣椒牛肉丝好吃。喵奶奶说剩下的牛排都这样炒来吃吧？我说早知今日，何必当初！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->成都·江安花园<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/d1840ee6gy1hq1nup9df">https://tvax3.sinaimg.cn/large/d1840ee6gy1hq1nup9df</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OfUmdBuGa">今天有网友发现，喵爷爷切肉用的张小泉菜刀。问那把德国双立人菜刀呢？有图有真相，拿去砍树了。 查看图片 - 转发 @种豆不高山:&amp;ensp;喵奶奶今天摘🍒的时候，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ofumdbuga/">
    
    
    
    
    
      
    
    今天有网友发现，喵爷爷切肉用的张小泉菜刀。问那把德国双立人菜刀呢？有图有真相，拿去砍树了。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@种豆不高山<!-- raw HTML omitted -->: 喵奶奶今天摘🍒的时候，突然发现长得 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OfVxo1oDl">喵奶奶给菜园安装了自动滴灌系统，不知道能不能旱涝保收？ [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ofvxo1odl/">
    
    
    
    
    
      
    
    喵奶奶给菜园安装了自动滴灌系统，不知道能不能旱涝保收？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d">https://tvax4.sinaimg.cn/large/d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OfXJdnLW1">五月是硕博士生的答辩季，而我的博士论文答辩在一月，硕士论文答辩在十二月。博士答辩见2007年天涯旧文《追怀启功先生：我的博士论文答辩》。此文前些年被微信公...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ofxjdnlw1/">
    
    
    
    
    
      
    
    五月是硕博士生的答辩季，而我的博士论文答辩在一月，硕士论文答辩在十二月。博士答辩见2007年天涯旧文《追怀启功先生：我的博士论文答辩》。此文前些年被微信公众号发掘出来，疯传一时。现在来说说硕士论文答辩。<!-- raw HTML omitted --> 我是川师大古代文学第三届研究生，1982年春季入学，1984年冬季毕业答辩。第一届研究生论文答辩，我们旁听了。答辩委员会主席都是请的外地专家，北京王利器先生、南京卞孝萱先生、重庆徐无闻先生等，都是赞美之词。卞孝萱教授主持师姐<!-- raw HTML omitted -->@成都郑晔<!-- raw HTML omitted --> 论文《李颀诗校注》答辩，记得他用扬州普通话，抑扬顿挫地说，郑同学的硕士论 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OfWqFbFpL">看了一个宋襄公的视频，让我想到一位故人</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ofwqfbfpl/">
    
    
    
    
    
      
    
    看了一个宋襄公的视频，让我想到一位故人  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OfWUsfyop">布洛芬不吃：关节肌肉疼吃：胃疼右美沙芬不喝：剧烈咳嗽喝：轻度咳嗽但飘飘欲仙西替利嗪不吃：嗓子痒想咳嗽吃：思维迟滞氨溴索：不喝：痰黏在声带上说不出话喝：...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ofwusfyop/">
    
    
    
    
    
      
    
    布洛芬<!-- raw HTML omitted -->不吃：关节肌肉疼<!-- raw HTML omitted -->吃：胃疼<!-- raw HTML omitted --><!-- raw HTML omitted -->右美沙芬<!-- raw HTML omitted -->不喝：剧烈咳嗽<!-- raw HTML omitted -->喝：轻度咳嗽但飘飘欲仙<!-- raw HTML omitted --><!-- raw HTML omitted -->西替利嗪<!-- raw HTML omitted -->不吃：嗓子痒想咳嗽<!-- raw HTML omitted -->吃：思维迟滞<!-- raw HTML omitted --><!-- raw HTML omitted -->氨溴索：<!-- raw HTML omitted -->不喝：痰黏在声带上说不出话<!-- raw HTML omitted -->喝：10分钟吐一次痰<!-- raw HTML omitted --><!-- raw HTML omitted -->咖啡：<!-- raw HTML omitted -->不喝：思维迟滞<!-- raw HTML omitted -->喝：加剧咳嗽<!-- raw HTML omitted --><!-- raw HTML omitted -->我搁这调参是吧<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OfWXIBTeM">楽天的球衣[心] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ofwxibtem/">
    
    
    
    
    
      
    
    楽天的球衣<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfYOLfvpX">久保史绪里#久保史绪里手机博# 2024.05.25 20:03「非常」不 这不是制服嘛 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofyolfvpx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfYQuxoKp">久保史绪里#shiorigram# .#久保的排练服##东京巨蛋##排练期间备受照顾了##太中意了##穿了好几次##日本放送##衣袖折起来了# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofyquxokp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->.<!-- raw HTML omitted -->&lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfZ2VBsdI">久保史绪里[笑哈哈] - 转发 @AyaTea:&amp;ensp;吉田绫乃#吉田绫乃クリスティー##吉田绫乃克莉丝蒂# 【手机邮】 240506 Part2（3）时间： 2024年5月6日 13:08标题： ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofz2vbsdi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[笑哈哈]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/lxh/lxh_xiaohaha-56dbc288a5.png%22">https://h5.sinaimg.cn/m/emoticon/icon/lxh/lxh_xiaohaha-56dbc288a5.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OfSL0w25d">通过测试，五星好评[彩虹屁][彩虹屁][彩虹屁] - 转发 @棋士柯洁:&amp;ensp;回学校参加游泳测试～通过以后还有奖牌纪念品[送花花]五星好评[赢牛奶] 北京·清华大学经...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ofsl0w25d/">
    
    
    
    
    
      
    
    通过测试，五星好评<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[彩虹屁]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/4b/2022_praise_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/4b/2022_praise_org.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/22041272/answer/3509824648">猫哥的视界回答了问题: 为什么海康能做大？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-22041272-answer-3509824648/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/268382431/answer/3509826456">猫哥的视界回答了问题: 在外国人眼中，中国的发展有多快？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-268382431-answer-3509826456/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/315477251/answer/3509823783">猫哥的视界回答了问题: 做安防的出路在哪里？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-315477251-answer-3509823783/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/603825548/answer/3509393758">张敬信回答了问题: 如何将两个EXCEL表中数据做对比找出差异？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-603825548-answer-3509393758/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699794681">量子位发表了文章: AI独角兽集体求卖身，新一轮洗牌期开始了</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699794681/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699797850">量子位发表了文章: 鹅厂造了个AI翻译公司：专攻网络小说，真人和GPT-4看了都说好</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699797850/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699797998">量子位发表了文章: 大模型“国家队”发力了 ，中国移动发布“万百千”</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699797998/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/699813016">量子位发表了文章: 无障碍化身小黑子只需6枚传感器，来自清华轻量化动捕新成果｜SIGGRAPH 2024</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-25</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-699813016/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

